Nutriband Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
NTRB Nasdaq 2830 www.nutriband.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nutriband Inc.

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 - Oct 13th, 2026 6:00 am
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology - Oct 8th, 2026 5:00 am
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders - Oct 1st, 2026 2:05 pm
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis - Sep 29th, 2026 7:25 am
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board - Sep 25th, 2026 6:00 am
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing - Sep 22nd, 2026 6:00 am
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit - Sep 9th, 2026 7:20 am
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch - Sep 8th, 2026 7:00 am
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Aug 13th, 2026 5:00 am
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference - May 15th, 2026 5:00 am
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast - Apr 22nd, 2026 5:00 am
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - Mar 30th, 2026 2:05 pm
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica - Mar 18th, 2026 5:00 am
The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable - Jan 29th, 2026 12:59 pm
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio - Dec 29th, 2025 7:00 am